Boeing will lower headcount by 30,000 positions over two years, including 7,000 through the end of this year, due to a prolonged commercial travel downturn and the hit from 737 MAX.
The latest announcements will shrink headcount down to 130,000 from 160,000 in January of this year, a drop of nearly 19 percent in less than two years.
A sharp drop in commercial plane travel has prompted airlines to cancel plane orders or defer deliveries, crimping Boeing’s revenues.
The company’s finances are also hampered by the grounding of the Boeing 737 MAX since March 2019.
It is nearing regulatory approval to resume service after a lengthy oversight process with air travel authorities.
In the third quarter, Boeing reported a loss of $449 million, compared with profits of $1.2 billion in the year-ago period as revenues fell 29.2 percent to $14.1 billion.
According to CEO Dave Calhoun, the pandemic is continuing to add pressure to Boeing's operations this quarter, forcing it to closely manage liquidity and transform it to be sharper, more resilient, and more sustainable for the long term.
Calhoun emphasized that Boeing is facing a difficult medium-term environment, with airline demand eventually returning.
He added that Boeing is well-positioned in the defense and space business, which is steadier than commercial travel.
Other cost-saving moves by Boeing include suspending dividend payments, trimming commercial plane production, and consolidating 787 Dreamliner plane manufacturing to one venue from two.
The company has also taken steps to raise cash, undertaking a $25 billion bond offering in the spring.


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Washington Post Publisher Will Lewis Steps Down After Layoffs
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 



